v3.25.2
Collaboration and Strategic Alliances (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2025
Oct. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Deferred revenue     $ 17,456   $ 17,456   $ 0
License              
Net product and licensing revenue     27,544 $ 0 27,544 $ 0  
Novo Nordisk | License              
Proceeds from collaborators $ 45,000            
Variable consideration, regulatory milestones 485,000            
Variable consideration, sales milestones $ 475,000            
Net product and licensing revenue     27,500        
Deferred revenue     $ 17,500   $ 17,500    
Viatris Inc. | License              
Proceeds from collaborators   $ 25,000